Login

Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients (4195)

DOI: 10.1212/wnl.96.15_supplement.4195 Publication Date: 2023-12-07T05:55:31Z
Abstract Supplemental Material References Cited by
AUTHORS (27)
Hani Kushlaf
Shahram Attarian
Joao Lindolfo Borges
Francoise Bouhour
Yin-Hsiu Chien
Young-Chul Choi
Paula Clemens
John Day
Jordi Diaz-Manera
Sevim Erdem-Ozdamar
Ozlem Goker-Alpan
Sergey Illarioshkin
Priya Kishnani
Anna Kostera-Prus...
Shafeeq Ladha
Tahseen Mozaffar
Mark Roberts
Volker Straub
Antonio Toscano
Ans van der Ploeg
Kristina An Haack
Christopher Hug
Olivier Huynh-Ba
Tianyue Zhou
Judith Johnson
Mazen Dimachkie
Benedikt Schoser
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
CROSSREF - Publications  OPENAIRE - Products 
PlumX Metrics
Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients (4195) 
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....

Powered by

  • AIX SEMS NFDI4DS

Legal

  • Impressum Datenschutz

Connect